To metastasise, cancer cells need to escape anoikis – apoptosis induced by loss of cell-matrix adhesion. Invasive lobular cancer (ILC) is a major breast cancer type that is particularly prone to metastasise owing to its intrinsic anoikis resistance and infiltrative growth pattern. Current treatments for breast cancer are often ineffective for metastatic ILC. To understand the basis of anoikis-resistance mechanisms in this disease, Patrick Derksen’s group used mouse ILC models and performed genome-wide mRNA profiling. They found that, in ILC cells, anchorage independency is mediated by the upregulation of Wnt11 (a noncanonical Wnt signal), which, in turn, is controlled by the nuclear translocation of p120-catenin (a protein involved in cell-cell adhesion processes) through inhibition of Kaiso-mediated transcriptional repression. In addition, Wnt11 promotes activation of RhoA – a member of the Rho-Rock pathway that drives ILC anoikis resistance and subsequent tumour growth and metastasis. This study identifies a p120/Kaiso/Wnt11-dependent autocrine RhoA activation loop that drives anchorage independence and underpins the use of Rho-Rock targeting as a therapeutic strategy in the treatment of metastatic ILC. Page 373
Elucidating metastasis mechanisms in lobular breast cancer
Elucidating metastasis mechanisms in lobular breast cancer. Dis Model Mech 1 April 2015; 8 (4): e0403. doi:
Download citation file:
Advertisement
Cited by
Call for Papers – Infectious Disease: Evolution, Mechanisms and Global Health
Showcase your latest research on our upcoming Special Issue: Infectious Disease: Evolution, Mechanisms and Global Health. This issue will be coordinated by DMM Editors Sumana Sanyal and David Tobin alongside Guest Editors Judi Allen and Russell Vance. The deadline for submitting articles to this Special Issue has been extended to Monday 24 February 2025.
Biologists @ 100 - join us in Liverpool in March 2025
We are excited to invite you to a unique scientific conference, celebrating the 100-year anniversary of The Company of Biologists, and bringing together our different communities. The conference will incorporate a DMM programme on antimicrobial resistance on 26 March 2025. Find out more and register to join us in March 2025 in Liverpool, UK.
It's about time: the heterochronic background for the 2024 Nobel Prize in Physiology or Medicine
In this Editorial, Bruce Wightman writes about the groundwork laid by investigating the timing of developmental events in nematodes which led to the 2024 Nobel Prize in Physiology or Medicine.
Read & Publish Open Access publishing: what authors say
We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Other journals from
The Company of Biologists